Metagenomi Therapeutics, Inc. - Common Stock (NQ:MGX)

0.7707 -0.0349 (-4.33%)

Delayed Quote Updated: 3:36 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Metagenomi Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week ↗

March 16, 2025

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.

Via Stocktwits

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

March 13, 2025

From Metagenomi, Inc.

Via GlobeNewswire

Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

February 11, 2025

From Metagenomi, Inc.

Via GlobeNewswire

Stargate, Netflix, GE Aerospace, Twilio, and More ↗

January 29, 2025

There's a lot for investors to talk about.

Via The Motley Fool

Expert Outlook: Metagenomi Through The Eyes Of 4 Analysts ↗

December 10, 2024

Via Benzinga

Trump’s “Stargate AI” Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO

January 22, 2025

Via AB Newswire

Topics Artificial Intelligence Government

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 22, 2025

Via Benzinga

Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

January 22, 2025

Via Benzinga

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

January 16, 2025

From Metagenomi, Inc.

Via GlobeNewswire

Metagenomi Announces New Appointment to its Board of Directors

January 15, 2025

From Metagenomi, Inc.

Via GlobeNewswire

Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 08, 2025

From Metagenomi, Inc.

Via GlobeNewswire

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

December 11, 2024

From Metagenomi, Inc.

Via GlobeNewswire

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

December 09, 2024

From Metagenomi, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 09, 2024

Via Benzinga

FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

November 25, 2024

From Faruqi & Faruqi, LLP

Via Business Wire

MGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

November 24, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)

November 22, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

DEADLINE NEXT WEEK: Berger Montague Advises Metagenomi (NASDAQ: MGX) Investors to Contact the Firm Before November 25, 2024

November 22, 2024

From Berger Montague

Via GlobeNewswire

METAGENOMI, INC. (NASDAQ: MGX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Metagenomi, Inc. Investors of Upcoming Deadline

November 19, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

METAGENOMI ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Metagenomi, Inc. and Encourages Investors to Contact the Firm

November 18, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

November 18, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

METAGENOMI (NASDAQ: MGX) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by November 25, 2024

November 18, 2024

From Berger Montague

Via GlobeNewswire

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

November 15, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results

November 13, 2024

From Metagenomi, Inc.

Via GlobeNewswire

MGX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX

November 12, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

NASDAQ: MGX DEADLINE REMINDER: Berger Montague Reminds Metagenomi (NASDAQ: MGX) Investors of Important Class Action Lawsuit Deadline

November 12, 2024

From Berger Montague

Via GlobeNewswire

METAGENOMI, INC. (NASDAQ: MGX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Metagenomi, Inc. Investors of Upcoming Deadline

November 12, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

METAGENOMI ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Metagenomi, Inc. and Encourages Investors to Contact the Firm

November 11, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

MGX DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX

November 07, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

November 06, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.